室性心律失常预测多发性肌炎/皮肌炎合并心肌受累患者不良结局
该回顾性队列研究纳入75例PM/DM合并心肌受累患者,中位随访24个月,27例(36%)达到复合终点。室性心律失常(VA)是复合终点的独立预后因素(HR 4.215),合并VA者3年无事件生存率显著低于无VA者(40.7% vs 63.3%,P=0.034)。
要点
- VA是PM/DM-MCI患者复合终点(全因死亡或心脏原因再住院)的独立预后因素。
- NT-proBNP>3415 pg/ml、间质性肺病及未接受抗心脏重构治疗亦为独立预后因素。
- 皮肤病变与抗线粒体抗体阳性分别是VA的独立预测因素。
核心结论
- VA为PM/DM-MCI患者提供预后信息并预测不良结局。
- 多发性肌炎和抗线粒体抗体阳性与PM/DM-MCI患者VA的存在密切相关。
研究设计与样本
- 回顾性队列研究,纳入北京协和医院1997年10月至2019年4月收治的75例PM/DM-MCI患者(44例PM,31例DM)。
- 分析VA及其他可能危险因素与复合终点(全因死亡和心脏原因再住院)的关系,中位随访24个月。
主要发现
- 27例(36%)患者在中位随访24个月内达到复合终点。
- 复合终点的独立预后因素包括VA(HR 4.215,95%CI 1.737–10.230)、NT-proBNP>3415 pg/ml(HR 2.606,95%CI 1.203–5.646)、间质性肺病(HR 2.688,95%CI 1.209–5.978)和抗心脏重构治疗(HR 0.302,95%CI 0.115–0.792)。
- 无VA患者3年无事件生存率显著高于有VA患者(63.3% vs 40.7%,P=0.034)。
- 皮肤病变(OR 0.163,95%CI 0.051–0.523)和抗线粒体抗体阳性(OR 3.484,95%CI 1.192–10.183)是VA的独立预测因素。
临床怎么用
- 对PM/DM-MCI患者应评估VA以进行预后分层。
- 合并VA、NT-proBNP>3415 pg/ml或间质性肺病者提示预后较差。
- 抗心脏重构治疗与改善复合终点相关(HR 0.302)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Myocardial involvement (MCI) is known to increase morbidity and mortality in polymyositis (PM) and dermatomyositis (DM). This study aims to investigate whether complicating with ventricular arrhythmia (VA) predicts poor outcomes in patients with PM/DM-related myocardial involvement (PM/DM-MCI). METHODS: We reviewed all PM/DM-MCI patients admitted to Peking Union Medical College Hospital from October 1997 to April 2019. VA and the other possible risk factors for the composite endpoint, including death from any cause and rehospitalization for cardiac causes, were analyzed. RESULTS: A total of 75 PM/DM-MCI patients (44 PM and 31 DM) were enrolled, of which 27 (36%) met the composite endpoint during a median follow-up of 24 months. Independent prognostic factors for the composite endpoint include VA [HR 4.215, 95% CI (1.737, 10.230)], NT-proBNP > 3415 pg/ml [HR 2.606, 95% CI (1.203, 5.646)], interstitial lung disease [HR 2.688, 95% CI (1.209, 5.978)], and anti-cardiac remodelling therapy [HR 0.302, 95% CI (0.115, 0.792)]. The 3-year event-free survival rate of patients without VA was significantly higher than that of patients with VA (63.3% vs 40.7%, P = 0.034). Skin lesions [OR 0.163, 95% CI (0.051, 0.523)] and positive antimitochondrial antibody [OR 3.484, 95% CI (1.192, 10.183)] were independent predictors of VA. CONCLUSION: VA provides prognostic insights for PM/DM-MCI patients and predicts poor outcome. Polymyositis and positive antimitochondrial antibody are closely associated with the presence of VA in PM/DM-MCI.
引用
- Huang Y, Liu H, Wu C, et al. Ventricular arrhythmia predicts poor outcome in polymyositis/dermatomyositis with myocardial involvement. Rheumatology (Oxford). 2021. PMID: 33369674. doi:10.1093/rheumatology/keaa872
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。